Global Bio-Chem Technology Group Completes Private Placement and Convertible Bond Conversion, Issuing Over 2.75 Billion New Shares-To The Moon - Tiger Brokers Online Investing Community - To The Moon

Like
Comment
Favorite

Global Bio-Chem Technology Group Completes Private Placement and Convertible Bond Conversion, Issuing Over 2.75 Billion New Shares

Reuters2025-10-02

<a href="https://laohu8.com/S/00809">Global Bio-Chem</a> Technology Group Completes Private Placement and Convertible Bond Conversion, Issuing Over 2.75 Billion New Shares

Global Bio-Chem Technology Group Co. Ltd. has announced the completion of a significant equity transaction involving the issuance of 2,752,605,977 new consideration shares under a specific mandate. The move forms part of a broader suppliers' debt restructuring arrangement. The company also confirmed the conversion of its convertible bonds as part of the deal. Following the transaction, key shareholdings are now attributed to entities including ShengLi IX and Modern Agricultural Industry Investment Holdings Limited, with indirect interests held by various investment funds and state-owned enterprises. The transaction aims to improve the company's financial position and broaden its shareholder base.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Global Bio-Chem Technology Group Co. Ltd. published the original content used to generate this news brief on October 02, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Like

Report

Comment

empty

No comments yet

Most Discussed

7x24

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/2572851940?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-02 19:11","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2572851940","market":"us","top_or_hot":-1,"title":"Global Bio-Chem Technology Group Completes Private Placement and Convertible Bond Conversion, Issuing Over 2.75 Billion New Shares","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      <a href=\"https://laohu8.com/S/00809\">Global Bio-Chem</a> Technology Group Completes Private Placement and Convertible Bond Conversion, Issuing Over 2.75 Billion New Shares\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Global Bio-Chem Technology Group Co. Ltd. has announced the completion of a significant equity transaction involving the issuance of 2,752,605,977 new consideration shares under a specific mandate. The move forms part of a broader suppliers' debt restructuring arrangement. The company also confirmed the conversion of its convertible bonds as part of the deal. Following the transaction, key shareholdings are now attributed to entities including ShengLi IX and Modern Agricultural Industry Investment Holdings Limited, with indirect interests held by various investment funds and state-owned enterprises. The transaction aims to improve the company's financial position and broaden its shareholder base.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Global Bio-Chem Technology Group Co. Ltd. published the original content used to generate this news brief on October 02, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Global Bio-Chem Technology Group Completes Private Placement and Convertible Bond Conversion, Issuing Over 2.75 Billion New Shares</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGlobal Bio-Chem Technology Group Completes Private Placement and Convertible Bond Conversion, Issuing Over 2.75 Billion New Shares\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-10-02 19:11</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      <a href=\"https://laohu8.com/S/00809\">Global Bio-Chem</a> Technology Group Completes Private Placement and Convertible Bond Conversion, Issuing Over 2.75 Billion New Shares\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Global Bio-Chem Technology Group Co. Ltd. has announced the completion of a significant equity transaction involving the issuance of 2,752,605,977 new consideration shares under a specific mandate. The move forms part of a broader suppliers' debt restructuring arrangement. The company also confirmed the conversion of its convertible bonds as part of the deal. Following the transaction, key shareholdings are now attributed to entities including ShengLi IX and Modern Agricultural Industry Investment Holdings Limited, with indirect interests held by various investment funds and state-owned enterprises. The transaction aims to improve the company's financial position and broaden its shareholder base.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Global Bio-Chem Technology Group Co. Ltd. published the original content used to generate this news brief on October 02, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1212","symbol_name":"农产品","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251002:nNDL7vCBcN:1","article_id":"2572851940","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2572851940","pubTimestamp":1759403519,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Global Bio-Chem Technology Group Completes Private Placement and Convertible Bond Conversion, Issuing Over 2.75 Billion New Shares. Global Bio-Chem Technology Group Co. Ltd. has announced the completion of a significant equity transaction involving the issuance of 2,752,605,977 new consideration shares under a specific mandate. The move forms part of a broader suppliers' debt restructuring arrangement. The company also confirmed the conversion of its convertible bonds as part of the deal. Following the transaction, key shareholdings are now attributed to entities including ShengLi IX and Modern Agricultural Industry Investment Holdings Limited, with indirect interests held by various investment funds and state-owned enterprises. The transaction aims to improve the company's financial position and broaden its shareholder base.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely informa","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1212":"农产品","00809":"大成生化科技"},"translate_title":"环球生化科技集团完成定向增发及可转债转股发行超27.5亿新股","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"00809":0.9},"content_text":"Global Bio-Chem Technology Group Completes Private Placement and Convertible Bond Conversion, Issuing Over 2.75 Billion New Shares\n    \n\n        Global Bio-Chem Technology Group Co. Ltd. has announced the completion of a significant equity transaction involving the issuance of 2,752,605,977 new consideration shares under a specific mandate. The move forms part of a broader suppliers' debt restructuring arrangement. The company also confirmed the conversion of its convertible bonds as part of the deal. Following the transaction, key shareholdings are now attributed to entities including ShengLi IX and Modern Agricultural Industry Investment Holdings Limited, with indirect interests held by various investment funds and state-owned enterprises. The transaction aims to improve the company's financial position and broaden its shareholder base.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Global Bio-Chem Technology Group Co. Ltd. published the original content used to generate this news brief on October 02, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"hasMoreComments":false,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"isCrawlerRequest":true}